眼动脉动脉瘤的显微外科夹闭:208个动脉瘤的手术结果与视力结局
该研究回顾性分析198例患者共208个眼动脉动脉瘤的显微夹闭结果:尽管20%为大型或巨大型动脉瘤,完全闭塞率达91%,眼动脉通畅率99.5%,复发率3.1%,再治疗率0%;术后新发视野缺损8例(3.8%)、视力下降5例(2.4%)、单眼盲9例(4.3%);作者认为夹闭最重要的风险是新发视力缺损。
要点
- 208个眼动脉动脉瘤完全闭塞率91%,眼动脉通畅率99.5%,复发率3.1%,再治疗率0%。
- 术后新发视野缺损8例(3.8%)、视力下降5例(2.4%)、单眼盲9例(4.3%)。
- 17例术前视力缺损者中9例(52.9%)视力改善;作者强调精细显微技术以优化视力结局。
核心结论
- 作者认为夹闭眼动脉动脉瘤最重要的风险是新发视力缺损,需在前床突切除、动脉瘤分离和夹闭时采用精细显微技术以优化视力结局。
- 作者指出术后积极的医疗管理可能降低迟发性视力缺损的发生率。
- 作者认为随着血管内治疗尤其是血流导向装置结果的明确,需将其与这些手术基准比较以确定最佳实践。
研究设计与样本
- 回顾性分析198例患者共208个眼动脉动脉瘤的显微外科夹闭结果,记录并分析患者人口学、动脉瘤形态(大小、钙化等)、临床特征与结局。
主要发现
- 208个动脉瘤中20%为大型或巨大型,完全闭塞91%,眼动脉通畅99.5%,复发率3.1%,再治疗率0%。
- 改良Rankin量表评分0-2分的良好结局见于96.2%的总体患者,以及全部156例未破裂动脉瘤患者。
- 新发视野缺损(偏盲或象限盲)8例(3.8%),视力下降5例(2.4%),单眼盲9例(4.3%)。
- 17例术前视力缺损患者中9例(52.9%)视力改善。
临床怎么用
- 作者认为夹闭眼动脉动脉瘤时,前床突切除、动脉瘤分离和夹闭过程中需采用精细显微技术以优化视力结局。
- 作者认为术后积极的医疗管理可能降低迟发性视力缺损的发生率。
- 作者认为血流导向装置等血管内治疗的结果需与本研究的手术基准比较,以确定最佳实践。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVEWhile most paraclinoid aneurysms can be clipped with excellent results, new postoperative visual deficits are a concern. New technology, including flow diverters, has increased the popularity of endovascular therapy. However, endovascular treatment of paraclinoid aneurysms is not without procedural risks, is associated with higher rates of incomplete aneurysm occlusion and recurrence, and may not address optic nerve compression symptoms that surgical debulking can. The increasing endovascular management of paraclinoid aneurysms should be justified by comparisons to surgical benchmarks. The authors, therefore, undertook this study to define patient, visual, and aneurysm outcomes in the most common type of paraclinoid aneurysm: ophthalmic artery (OphA) aneurysms.METHODSResults from microsurgical clipping of 208 OphA aneurysms in 198 patients were retrospectively reviewed. Patient demographics, aneurysm morphology (size, calcification, etc.), clinical characteristics, and patient outcomes were recorded and analyzed.RESULTSDespite 20% of these aneurysms being large or giant in size, complete aneurysm occlusion was accomplished in 91% of 208 cases, with OphA patency preserved in 99.5%. The aneurysm recurrence rate was 3.1% and the retreatment rate was 0%. Good outcomes (modified Rankin Scale score 0-2) were observed in 96.2% of patients overall and in all 156 patients with unruptured aneurysms. New visual field defects (hemianopsia or quadrantanopsia) were observed in 8 patients (3.8%), decreased visual acuity in 5 (2.4%), and monocular blindness in 9 (4.3%). Vision improved in 9 (52.9%) of the 17 patients with preoperative visual deficits.CONCLUSIONSThe most important risk associated with clipping OphA aneurysms is a new visual deficit. Meticulous microsurgical technique is necessary during anterior clinoidectomy, aneurysm dissection, and clip application to optimize visual outcomes, and aggressive medical management postoperatively might potentially decrease the incidence of delayed visual deficits. As the results of endovascular therapy and specifically flow diverters become known, they warrant comparison with these surgical benchmarks to determine best practices.
引用
- Kamide T, Tabani H, Safaee MM, et al. Microsurgical clipping of ophthalmic artery aneurysms: surgical results and visual outcomes with 208 aneurysms. J Neurosurg. 2018. PMID: 29372879. doi:10.3171/2017.7.JNS17673
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。